Journal article
The emerging treatment landscape of advanced urothelial carcinoma
Abstract
PURPOSE OF REVIEW: Urothelial carcinoma (UC) is one of the most common malignancies in the Western world. Historically, patients with advanced disease have had a poor prognosis and progress within months of completing upfront platinum-based chemotherapy. In the last two years, the treatment landscape for metastatic UC (mUC) has significantly shifted with the emergence of contemporary immunotherapy and targeted agents. The purpose of this review …
Authors
Cardenas L; Dibajnia P; Lalani A-K
Journal
Current Opinion in Supportive and Palliative Care, Vol. 15, No. 4, pp. 247–252
Publisher
Wolters Kluwer
Publication Date
December 2021
DOI
10.1097/spc.0000000000000573
ISSN
1751-4258